Caraco Pharmaceuticals Private Limited
About Caraco Pharmaceuticals Private Limited
Data last updated:
Caraco Pharmaceuticals Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Faststone Mercantile Company Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2012FTC225970.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rakeshchandra Jagdishprasad Sinha and Prince Kalarickal Elias.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F P 145 Ram Mandir Road Vile Parle East, Mumbai, Maharashtra, India – 400057.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressF P 145 Ram Mandir Road Vile Parle East, Mumbai, Maharashtra, India – 400057
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Caraco Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2018-19 to FY 2021-22in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | •••• | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | •••• | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2022-23 | FY 2018-19 to FY 2021-22in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | •••• | |
| Net Profit Margin | •••• | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2018-19 to FY 2021-22, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Caraco Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Caraco Pharmaceuticals Private Limited
Caraco Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakeshchandra Jagdishprasad Sinha | Director | 29 Jan 2024 | 2 Years 8 Months | Current |
| Prince Kalarickal Elias | Director | 29 Jan 2024 | 2 Years 8 Months | Current |
| Kedar Nath Senapati | Additional Director | 29 Jul 2025 | 1 Years 2 Months | Current |
Auditor Details
Caraco Pharmaceuticals Private Limited is audited by S R B C & CO LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R B C & CO LLP | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Caraco Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Caraco Pharmaceuticals.
: available in the company report
Recent Activity
Caraco Pharmaceuticals Private Limited has 11 board changes on record since 2013: 4 appointments and 7 cessations. The latest: Kedar Nath Senapati was appointed as Additional Director on 29 Jul 2025.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Caraco Pharmaceuticals is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 January 2012 (14+ years old) and is registered under CIN U24100MH2012FTC225970.
Caraco Pharmaceuticals has 3 current directors:
- Rakeshchandra Jagdishprasad Sinha - Director
- Prince Kalarickal Elias - Director
- Kedar Nath Senapati - Additional Director
The latest financial statements of Caraco Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Caraco Pharmaceuticals is U24100MH2012FTC225970. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caraco Pharmaceuticals was incorporated on 12 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Kedar Nath Senapati was appointed as Additional Director on 29 Jul 2025. Prince Kalarickal Elias ceased to be Additional Director on 26 Sep 2024. Rakeshchandra Jagdishprasad Sinha ceased to be Additional Director on 26 Sep 2024. Caraco Pharmaceuticals has 11 board changes on record in total.
The registered office of Caraco Pharmaceuticals is at F P 145 Ram Mandir Road Vile Parle East, Mumbai, Maharashtra, India – 400057.
Caraco Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Caraco Pharmaceuticals is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.
Caraco Pharmaceuticals can be reached at its registered office: F P 145 Ram Mandir Road Vile Parle East, Mumbai, Maharashtra, India – 400057.